tiprankstipranks
Trending News
More News >
Acura Pharmaceuticals (ACUR)
OTHER OTC:ACUR
US Market

Acura Pharmaceuticals (ACUR) Ratios

Compare
83 Followers

Acura Pharmaceuticals Ratios

ACUR's free cash flow for Q4 2021 was $0.25. For the 2021 fiscal year, ACUR's free cash flow was decreased by $ and operating cash flow was $0.81. See a summary of the company’s cash flow.
Ratios
TTM
Dec 21Dec 20Dec 19Dec 18
Liquidity Ratios
Current Ratio
0.72 0.72 0.16 1.10-
Quick Ratio
0.72 0.72 0.16 1.10-
Cash Ratio
0.13 0.13 0.05 0.80-
Solvency Ratio
-1.16 -1.45 -0.20 -0.50-
Operating Cash Flow Ratio
-1.44 -1.44 -0.10 -0.58-
Short-Term Operating Cash Flow Coverage
-22.48 0.00 -0.12 0.00-
Net Current Asset Value
$ -310.00K$ -310.00K$ -6.45M$ -6.13M-
Leverage Ratios
Debt-to-Assets Ratio
0.23 0.17 3.61 2.34-
Debt-to-Equity Ratio
1.12 0.84 -1.06 -1.27-
Debt-to-Capital Ratio
0.53 0.46 16.58 4.77-
Long-Term Debt-to-Capital Ratio
0.46 0.46 -0.02 4.77-
Financial Leverage Ratio
4.83 4.83 -0.29 -0.54-
Debt Service Coverage Ratio
-2.53 -3.94 -0.16 -7.16-
Interest Coverage Ratio
-6.07 -6.07 -1.68 -1.61-
Debt to Market Cap
5.55 <0.01 0.92 0.98-
Interest Debt Per Share
<0.01 <0.01 0.21 0.24-
Net Debt to EBITDA
-0.23 -0.14 -9.25 -1.69-
Profitability Margins
Gross Profit Margin
94.24%22.52%99.95%99.94%-
EBIT Margin
-43.44%-43.44%-21.23%-124.65%-
EBITDA Margin
-37.68%-37.68%-17.73%-114.38%-
Operating Profit Margin
-77.67%-77.67%-21.23%-27.29%-
Pretax Profit Margin
-56.24%-56.24%-33.84%-142.04%-
Net Profit Margin
-56.24%-69.03%-46.44%-148.66%-
Continuous Operations Profit Margin
-56.24%-56.24%-33.84%-142.04%-
Net Income Per EBT
100.00%122.75%137.25%104.66%-
EBT Per EBIT
72.41%72.41%159.37%520.55%-
Return on Assets (ROA)
-102.21%-125.47%-95.51%-154.18%-
Return on Equity (ROE)
30.77%-606.18%28.14%83.32%-
Return on Capital Employed (ROCE)
-351.88%-351.88%13.10%-48.72%-
Return on Invested Capital (ROIC)
-295.38%-394.24%-275.23%-51.00%-
Return on Tangible Assets
-102.21%-255.69%-99.70%-225.46%-
Earnings Yield
-4000.00%-3.80%-24.43%-64.27%-
Efficiency Ratios
Receivables Turnover
9.89 9.89 5.69 13.70-
Payables Turnover
0.47 6.31 0.06 <0.01-
Inventory Turnover
0.00 0.00 0.00 0.00-
Fixed Asset Turnover
3.57 3.57 7.38 4.92-
Asset Turnover
1.82 1.82 2.06 1.04-
Working Capital Turnover Ratio
-0.48 -0.48 -1.14 -6.11-
Cash Conversion Cycle
-741.77 -20.97 -6.29K -57.45K-
Days of Sales Outstanding
36.90 36.90 64.11 26.65-
Days of Inventory Outstanding
0.00 0.00 0.00 0.00-
Days of Payables Outstanding
778.67 57.87 6.35K 57.48K-
Operating Cycle
36.90 36.90 64.11 26.65-
Cash Flow Ratios
Operating Cash Flow Per Share
-0.02 -0.01 -0.02 -0.02-
Free Cash Flow Per Share
-0.02 -0.01 -0.02 -0.02-
CapEx Per Share
0.00 0.00 0.00 0.00-
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00-
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 0.00 0.00-
Capital Expenditure Coverage Ratio
0.00 0.00 0.00 0.00-
Operating Cash Flow Coverage Ratio
-3.71 -4.95 -0.11 -0.10-
Operating Cash Flow to Sales Ratio
-0.47 -0.47 -0.20 -0.23-
Free Cash Flow Yield
-2248.42%-2.61%-10.59%-10.06%-
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.03 -26.32 -4.09 -1.56-
Price-to-Sales (P/S) Ratio
0.02 18.17 1.90 2.31-
Price-to-Book (P/B) Ratio
0.12 159.55 -1.15 -1.30-
Price-to-Free Cash Flow (P/FCF) Ratio
-0.04 -38.28 -9.44 -9.94-
Price-to-Operating Cash Flow Ratio
-0.03 -38.28 -9.44 -9.94-
Price-to-Earnings Growth (PEG) Ratio
>-0.01 0.42 0.06 0.09-
Price-to-Fair Value
0.12 159.55 -1.15 -1.30-
Enterprise Value Multiple
-0.29 -48.36 -19.97 -3.71-
Enterprise Value
168.00K 28.49M 12.64M 11.28M-
EV to EBITDA
-0.29 -48.36 -19.97 -3.71-
EV to Sales
0.11 18.22 3.54 4.25-
EV to Free Cash Flow
-0.23 -38.39 -17.58 -18.26-
EV to Operating Cash Flow
-0.23 -38.39 -17.58 -18.26-
Tangible Book Value Per Share
<0.01 <0.01 -0.18 -0.21-
Shareholders’ Equity Per Share
<0.01 <0.01 -0.18 -0.18-
Tax and Other Ratios
Effective Tax Rate
0.00 -0.23 -0.37 -0.05-
Revenue Per Share
0.04 0.03 0.11 0.10-
Net Income Per Share
-0.02 -0.02 -0.05 -0.15-
Tax Burden
1.00 1.23 1.37 1.05-
Interest Burden
1.29 1.29 1.59 1.14-
Research & Development to Revenue
0.98 0.98 0.50 0.57-
SG&A to Revenue
0.80 0.80 0.71 0.71-
Stock-Based Compensation to Revenue
0.04 0.04 0.01 0.04-
Income Quality
0.84 0.84 0.60 0.16-
Currency in USD